Marta Botelho
Faro, Algarve, 8005-139, Portugal
NCT Number: NCT04605900
This study determines the effectiveness of plantar orthoses and custom-made orthopedic footwear in functional level and quality of life of persons with diabetes type 2 and diabetic peripheral neuropathy. This study is important due the loss of protective sensation, feet are vulnerable to minor trauma caused by plantar pressure as well as mechanical and thermal injuries. Thus, Plantar Orthoses become necessary to reduce PP and align the foot. Additionally, it is known that footwear is the most frequent cause of diabetic foot injury, since ulceration is frequently a consequence of the continuous trauma provoked by inadequate footwear. For a higher efficacy in the treatment of the foot, it is also necessary to use custom-made orthopedic footwear, indicated in the treatment of foot pathologies.
The lack of studies that evaluate the impact of this treatment on clinical measures such as quality of life and functional level, led to the development of this study, comparing a standard treatment (standard footwear and plantar orthoses) with an optimal treatment suggested in diabetic foot guidelines (therapeutic footwear and plantar orthoses).
Looking for future studies?
Notify Me40 year–80 year
All sexes
Interventional
Not applicable
Faro, Algarve, 8005-139, Portugal
This clinical trial includes 2 parallel intervention groups with a pre- and post-test analysis. In the standard footwear (SF) group, plantar orthoses, standard footwear and education on foot self-care were applied and in the orthopedic footwear (OF) group the same intervention was applied, but with orthopedic footwear.
Both intervention groups were evaluated at two different time points, with the pre-test taking place at the beginning of the study (T0 - Baseline) and the post-test taking place 4 months after the application of the treatment (T4). In the middle of the study, at two months (T2) a questionnaire was applied in order to understand the adherence and the perception of individuals about the intervention applied.
The screening of diabetic peripheral neuropathy was made with the Michigan Neuropathy Screening Instrument (MNSI) and the description of the sample with an evaluation questionnaire.
The FL was evaluated through the Lower Extremity Functional Scale (LEFS), physical tests and the postural, static and dynamic barometric assessment. QoL was assessed with SF-36 and the adherence and satisfaction with a questionnaire created ad hoc.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The orthopedic footwear used by the OF Group was manufactured by the company J. Andrade Ferreira Neves Lda. with materials suitable for the diabetic foot, as registered with INFARMED under registration ID 279515.
In the SF Group, it was recommended to use standard shoes more suitable for diabetic foot, with some specific characteristics, such as sports or walking shoes. The acquisition or not of a more suitable shoes by the participants was at the discretion of each individual.
The plantar orthoses (PO) that both groups used for distribute of plantar loads was based on the principle of total contact. The confection material consisted in a liner of EVA shore 20º and polyurethane filling ELAX flexible (expandable) from OKM Química Ortopédica SL.
An information leaflet with foot care was delivered, with the aim of ensuring that participants were informed about the care they should continually take with their feet during the study period. This leaflet was created based on the guidelines of the "Associação Protetora dos Diabéticos" in Portugal.
Time frame: 4 months
Significantly change any subscore or total score of Medical Outcomes Study 36-item Short-Form Health Survey instrument, that was use it to assess quality of life. Instrument scores can range between 0 - 100. Higher values mean better self-perception of quality of life.
Time frame: 4 months
Change at least 9 points in Lower Extremity Functional Scale (minimum change for clinically relevant functional improvement). Instrument scores can range between 0 - 80. Higher values mean better functionality.
Time frame: 4 months
Significantly change the maximum distance (cm) attained in Functional Reach Test.
Time frame: 4 months
Change the time (s) in left and right unipedal stance.
Time frame: 4 months
Change the time (s) in full-tandem position.
Time frame: 4 months
Achieve at least 10 steps in full-tandem.
Time frame: 4 months
Change the time (s) in performing the Time Up and Go test.
Time frame: 4 months
Change the distance (m) covered for 6 minutes of walking.
Time frame: 4 months
Significantly change the length displacement (mm) of center of pressure.
Time frame: 4 months
Significantly change the amplitude mediolateral and anteroposterior displacement (mm) of Center of Pressure.
Time frame: 4 months
Significantly change the ellipse surface (mm2).
Time frame: 4 months
Significantly change the mean speed of CoP (mm/s).
Time frame: 4 months
Significantly change the mediolateral and anteroposterior standard deviation (mm).
Time frame: 4 months
Significantly change the root mean square index (mm).
Time frame: 4 months
Significantly change the romberg ration index (mm).
Time frame: 4 months
Change the mean pressure (kPa) on each foot in static position.
Time frame: 4 months
Change the maximum pressure (kPa) in each forefoot and hindfoot in static position.
Time frame: 4 months
Change the support surface (cm2) between the plantar surface and the platform sensors, during the support phase on each of the feet.
Time frame: 4 months
Change the load distribution (%) between each foot.
Time frame: 4 months
Change the maximum pressure (kPa) of each foot in gait.
Time frame: 4 months
Change the mean pressure (kPa) on each foot in gait.
Time frame: 4 months
Change the plantar impression Length (mm) of each of the feet.
Time frame: 4 months
Change the support surface (cm2) of each foot.
Time frame: 4 months
Change the longitude of the center of pressure (mm) of each foot.
Time frame: 4 months
Change the load distribution (%) between the forefoot and hindfoot and between the medial and lateral zone.
Time frame: 4 months
Change the foot progression angle in gait.
Time frame: 4 months
Change the double support time (ms) in gait.
Time frame: 4 months
Change the support time (ms) for each foot in gait.
Time frame: 4 months
Change the step length (m) in gait.
Time frame: 2 months
Number of hours per day using the devices (telephone monitoring).
Time frame: 2 months
Presence or not of improvements in feet/legs with the devices (telephone monitoring).
Time frame: 2 months
Level of Satisfaction (totally satisfied, quite satisfied, satisfied, little satisfied, dissatisfied) with the devices (telephone monitoring).
Universidade do Algarve
Other
Impact of Therapeutic Footwear and Plantar Orthoses for Patients With Diabetic Neuropathic Foot in Quality of Life and Functionality: A Interventional Study
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03252132
Diabetes Complications, Diabetes Mellitus
Aarhus, Denmark
View Trial DetailsNCT03913793
Cardiovascular Diseases, Diabetes Mellitus
View Trial DetailsNCT06797869
Diabetes Mellitus, Diabetes Mellitus, Type 2
La Mesa, California, United States
View Trial DetailsNCT06519942
Atrophy, Diabetes Mellitus
Ghent, Belgium
View Trial Details